Strata skin sciences surpasses 100 domestic installations of theraclear®x devices as of march 31, 2024

Horsham, pa., may 14, 2024 (globe newswire) -- strata skin sciences, inc. (“strata” or the “company”) (nasdaq: sskn), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announces its installed base of theraclear®x devices surpassed 100 at the end of the first quarter of 2024.
SSKN Ratings Summary
SSKN Quant Ranking